Abiopharma

Nuvation Bio Inc. - Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib(IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers